InvestorsHub Logo

kfcyahoo

03/06/20 11:35 PM

#284868 RE: Blue Fin #284864

"Review Article Supports Brilacidin’s Therapeutic Potential as a Defensin-Mimetic Drug Candidate"

Authored by a known slacker.

What do his old friends at the Boston Business Journal have
to say?

Why their silence? Part and parcel?